Studies were conducted in suckling mice to investigate copperdependent anemia. Brindled (Mobr/y) mice, which have a genetic defect that affects copper metabolism, were compared to their normal brothers
Pathophysiological consequences of cop-
A provocative study by Weisenberg et al. per deficiency affect many organ systems (3) in rats suggested that many of the effects because of the ubiquitous nature of copper-of copper deficiency were secondary to the dependent enzymes. The first biological iron-deficient state induced by dietary copsystem to be recognized as being dependent per deficiency, including anemia and growth on adequate dietary copper levels was the impairment, both of which were eliminated hematopoietic system when Hart et al. (1) by adding extra iron to the copper-deficient showed that both copper and iron were diet. The reversal of anemia and growth necessary to cure the anemia induced in rats reduction was accomplished without signififed a milk diet. Since then many studies cant increases in ceruloplasmin or cytohave demonstrated a nutritional interaction chrome oxidase activities, implying that the between copper and iron, but the etiology of rats were still "copper deficient." the copper-dependent anemia is still not completely resolved (2) . The consequences 
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Recent work has suggested that mice may be a useful model for the study of copperdependent anemia (2) . Human infants de velop anemia when copper is limited in the diet or parenteral solution, whereas humans with congenital copper deficiency, Menkes' steely-hair disease (4), do not develop ane mia. Dietary copper deficiency in neonatal mice results in anemia, whereas anemia is absent in brindled mice, the genetic analog of Menkes' disease in humans (5) . The pur pose of this study was to determine the ame liorative effects of copper or iron on neonatal mice that were copper-deficient because of diet fed to dams or because of the brindled mutation. Growth and hemoglobin status were monitored to compare with the previ ously mentioned rat study (3) and special emphasis was given to brain, since previous work (6) had compared these mice regarding abnormalities in brain catecholamine levels. Furthermore, it was assumed that the brain lesions were copper-and not iron-dependent.
METHODS
Animal care and diets. Hemizygous brindled males (Mobr/y) and their normal brothers (Mo+/y) were obtained from matings of heterozygous females (Mobr/+) with normal males. Mice were of the C57BL strain and were originally provided by Dr. Douglas Grahn, Argonne National Labora tory. These genetic breeding units were fed a nonpurified diet (Mouse Chow, Ralston Purina Co., St. Louis, MO) containing 12-14 ppm of copper and were given tap water (Cu 20 ng/ml) to drink. Copper-deficient ( â€" Cu) offspring were from normal dams (Mo*x*),given deionized water to drink and fed a purified diet low in copper (Teklad Laboratories, Madison, WI) modified by omitting cupric carbonate from the mineral mix (Modified AIN-76A). The composition of the purified diet and salt mix was similar to the AIN-76 diet described elsewhere (7) . The low copper diet contained 0.6 ppm cop per and 45 ppm iron when analyzed by atomic absorption spectroscopy following wet digestion in HNO3 (8) . The diet was fed throughout gestation and during lactation while the study was in progress. Coppersupplemented ( + Cu) offspring were de rived from dams fed the -Cu diet, but were given cupric sulfate in the drinking water (Cu 20^g/ml). Litter size was adjusted to eight pups per dam 2 days after birth. All litters were maintained in polycarbonate boxes on wood shavings with stainless-steel tops at 23Â°Cand 55% relative humidity with 12 hours of light.
Injection procedure. More than 200 mice were injected in these experiments, which were conducted over a period of 1 year. Doses of copper were patterned after the experiments of previous workers (9-11). When 7 days of age, male mice were given a 10-/il subcutaneous injection of either NaCl, FeCl2 or CuCl2 containing 50 Â¡ig of each respective metal. All solutions were prepared in 50% (vol/vol) glycerol. Mice injected with the NaCl or FeCl2 solutions received 1.3 or 0.9 ng of Cu, respectively, as a trace contaminant as determined by flameless atomic absorption spectroscopy of the injection solutions. Mice within a single litter were given all three treatments to min imize between-litter variability. Identifica tion was made by ear-punching. Five days later, when the mice were 12 days of age, the mice were killed by decapitation. This age was chosen to compare data with previous studies (6, 8) . A 5-/il aliquot of the blood was taken for hemoglobin determination as cyanmethemoglobin (8) and the remainder was allowed to clot. Serum was collected and assayed for ceruloplasmin activity by using o-dianisidine as substrate (8) .
Brain and liver tissue were rapidly re moved from the mice, rinsed in deionized water and used for trace metal or metabo lite analyses.
Chemical analyses. Total copper and iron were determined on fresh liver and brain tissue by flame atomic absorption spectros copy (Perkin-Elmer model 2380, PerkinElmer Corp., Norwalk, CT) following wet digestion (8) . Serum copper was determined by electrothermal atomization by using a graphite furnace fitted with an autosampler (Perkin-Elmer HGA-400 and AS-40) by in jecting 20-/il samples of the serum, which was diluted 20-fold in 10 mM HNO3 (INSTRA-ANALYZED grade, J. T. Baker Co., Phillipsburg, NJ). The graphite furnace was programmed as follows: step 1, 120Â°C, 5 second ramp, 60 second hold; step 2, 700 Â°C, 20 second ramp, 15 second hold; step 3, 2700 Â°C, 0 second ramp, 3 second hold, flow of argon reduced to 50 ml/minute; step 4, 2700 Â°C, 0 second ramp, 3 second hold. A serum standard as well as aqueous standards were also analyzed concurrently.
Whole-brain samples, less olfactory lobes, were analyzed for norepinephrine and dopamine by extracting the tissue with cold perchloric acid, isolating the catecholamines on alumina and quantifying them by high performance liquid chromatography (HPLC) with electrochemical detection as described previously (6) .
Statistical analyses. Sample means were compared by Student's two-tailed i-test after variance equality was established by the Ftest (12) . Comparisons were made between mouse types (+Cu, -Cu, Mo+/y, and Mobr/y) for a given treatment as well as between treatments (NaCl, FeCl2, and CuCl2) for a given mouse type. Mean com parisons resulting in P < 0.05 were consid ered significantly different.
RESULTS
Mice of all four groups ( + Cu, â€" Cu, Mo+/y, Mobr/y) tolerated the doses of NaCl, FeCl2 and CuCl2 given. There were small necrotic patches observed near the injection site in many mice given copper. The only other visible evidence of change due to in jection treatment was a darkened coat color of the brindled mice given CuCl2. No ap preciable change in mortality or motility was observed over the 5-day treatment period compared to mice not injected.
Injection of CuCl2 into -Cu male off spring resulted in an improvement in growth adjudged by both an overall increase in body weight as well as an improvement in brain weight when compared to â€" Cu mice given NaCl or FeCl2 (table 1) . However, at 12 days of age, the -Cu mice treated with CuCl2 were still smaller in size and had smaller brain weights than the correspond ing control mice (+Cu or Mo+/y) (table 1).
Injection of FeCl2 or CuCl2 into +Cu, Mo*'y or Mobr/y mice did not alter body or brain weight compared to mice given NaCl. The Mobâ"¢y mice were smaller in size and had smaller brains than the + Cu or Mo*'y mice, but had values equivalent to -Cu mice in all cases (table 1).
Liver. In liver copper and iron levels the injection regimen produced some interesting changes, which were dependent on both diet and genetics (table 2) . Liver copper levels of -Cu offspring were higher than levels in Mo*'y offspring when comparing NaCl-or FeCl2-injected mice FeCl2 injection did not alter liver copper levels, but CuCl2 did (table 2) . In fact, a dramatic rise (3.2-to 5.3-fold) in liver copper levels was observed; levels in +Cu and Mo*'y offspring were now equivalent. Liver iron levels were not altered by injection treatment in either + Cu or Mo+/y mice, and values were equivalent between them. Liver copper levels were lowest in -Cu mice injected with NaCl or FeCl2 but rose dramatically (85-fold) following CuCl2 injection to levels not significantly different from +Cu or Mo*'y (table 2). FeCl2 injection did not alter liver copper levels in -Cu mice but did cause a further elevation (2.7-fold) in liver iron levels compared to -Cu mice given NaCl. CuCl2 injection into -Cu mice lowered liver iron levels (25%) to control levels. Brindled mice injected with NaCl had low liver copper levels compared to + Cu or Mo*'y, but slightly higher than those observed in â€" Cu mice (table 2) . Liver iron levels were highest in Mo^'y mice given NaCl. When injected with FeCl2, Mobr/y mice accumulated more iron; the elevated levels were equivalent to those of -Cu but much higher (3-fold) than those of + Cu or Mo*'y. Injection of CuCl2 into Mobr/y mice elevated liver copper levels to 25 ppm, basal control levels, but this response was much lower than that observed in the other three types of mice (table 2) . Furthermore, CuCl2 injection did not lower liver iron levels in Mobr/y mice in contrast to -Cu mice given CuCl2, but rather the response to CuCl2 for liver iron was similar to control mice, i.e., no effect.
Blood. Several components of blood were affected by the injection protocols (table 3) . Control mice, +Cu and Mo*'y, showed modest increases in serum copper levels following CuCl2 injection, but no elevation in ceruloplasmin activity or in hemoglobin levels. Response in -Cu mice was quite interesting. Injection of â€" Cu mice with NaCl resulted in mice that were anemic (compared to all other mice), with low 10 .5b (7) 9.79b (7) 30.6b (12) 'Values are means Â±SD(number of mice in parentheses) of 12-day-old male C57BL mice. When 7 days old, mice were given a 10-^1injection subcutaneously containing 50 fig,of the metal as the chloride salt dissolved in 50% glycerol. Details of the production of dietary copper deficiency ( -Cu) and genetic brindled mutants (Mobr/y) are given in the text.
2Numbers within a row not sharing a common lower case superscript (comparison be tween mice) and numbers within a column not sharing a common upper case superscript (comparison between treatments) are significantly different (P < 0.01) by Student's i-test.
serum copper levels and ceruloplasmin ac-rise quite dramatically, 17.5-and 52.6-fold, tivities (table 3) . Injection of FeCl2 into respectively. Basal serum copper levels in â€" Cu mice did not significantly raise serum Mo^'y mice were higher than those obcopper levels but did cause a small (from served in â€" Cu mice but much lower than 0.27 to 0.75 U/L) rise in ceruloplasmin ac-either of the control groups (table 3) . Injectivity. Furthermore, FeCl2 treatment of tion of FeCl2 compared to NaCl did not -Cu mice raised hemoglobin to levels raise the serum copper or ceruloplasmin equivalent to +Cu and Mo+/yoffspring but levels of Mobr/y mice, but CuCl2 did, 8.5-below Mobr/y levels (table 3). Injection of and 12.1-fold, respectively. In fact, the ceruCuCl2into -Cu mice had the same effect as loplasmin activity of Mobr/y mice injected FeCl2 on the hemoglobin response but with CuCl2 was higher than the other three caused serum copper and ceruloplasmin to groups of mice (table 3). Hemoglobin levels (5) 'Values are means Â±SD(number of mice in parentheses) of 12-day-old male C57BL mice. Other details of the protocol can be found in table 1. 2Numbers within a row not sharing a common lower case superscript (com parison between mice) and numbers within a column not sharing a common upper case superscript (comparison between treatments) are significantly different (P < 0.02 liver copper, P < 0.05 liver iron) by Student's i-test. Â±0.76Â°* (7) 11.0 Â±1.31bB (11) 11.4 Â±1.61bAB (14) 'Values are means Â±SD(number of mice in parentheses) of 12-day-old male C57BL mice Other details of the protocol can be found in table 1. 'Numbers within a row not sharing a common lower case superscript (com parison between mice) and numbers within a column not sharing a common upper case superscript (comparison between treatments) are significantly different (P < 0.01) by Student's t-test.
of Mobr/y mice were not greatly altered by FeCl2 or CuCl2 treatment and were some what higher than the levels observed in the other three mouse types (table 3) .
Brain. Brain trace metal levels and catecholamine concentrations were changed as a result of the injection treatments, but the changes were dependent on both diet and genetics. Injection of FeCl2 or CuCI2 into + Cu or Mo+/y mice did not alter brain levels of copper ( fig. 1 ) or iron (table 4) compared to NaCl injection. Mean values for both trace metals for +Cu and Mo*m ice were similar to one another regardless of treatment. Injection of FeCl2 into -Cu mice did not alter brain copper ( fig. 1 ) or iron levels (table 4), but injection of CuCl2 elevated the low levels of brain copper ob served in -Cu mice treated with NaCl or FeCl2 3.5-fold to levels observed in +Cu and Mo*'y mice ( fig. 1 ). Brain iron was less changed by CuCl2 treatment of â€" Cu mice Brain iron levels of Mobr/y mice were not altered by injection treatments (table 4) and were similar to levels observed in the other mice Brain copper levels, on the other hand, were low in Mobr/y mice injected with NaCl or FeCl2, equivalent to -Cu mouse levels ( fig. 1) . When Mobr/y mice were injected with CuCl2, brain copper levels rose, but only 1.9-fold, and this rise resulted in levels much lower than those observed in any of the other CuCl2-treated mice ( fig. 1) . The mean value for CuCl2-treated Mobr/y mice of 0.64 /ig/g was well below the mean for -Cu brain of 1.1 /tg/g.
The changes in brain copper levels in treated mice reflected changes in catecholamine levels. Injection of FeCl2 and CuCl2 into control mice was without effect on brain norepinephrine ( fig. 2) or dopamine (table 4) levels compared to mice treated with NaCl. Mean values were equivalent for + Cu and Mo*'y mice regardless of treat ment. Injection of CuCl2 into -Cu mice elevated the depressed basal levels of nor epinephrine observed in NaCl-and FeCl2-treated mice to levels equivalent to those measured in +CU and Mo+/y mice given CuCl2 ( fig. 2 ). CuClu treatment, but not FeCl2 treatment, of -Cu mice tended to lower dopamine levels but not significant ly (P > 0.05) (table 4) Mobr/ymice, injected with either NaCI, FeCl2 or CuCU, respectively. Brain copper levels were lower in -Cu and Mobr/y mice given NaCI or FeCl2, but levels were equivalent (P < 0.01). Injection of CuClj raised -Cu levels (P < 0.01) to levels equal to +Cu and Mo*'y but higher than Mobr/ylevels despite a significant rise in Mobr/!'mice due to CuClz (P < 0.01). Control brain copper levels were not elevated by any treatment. norepinephrine ( fig. 2) or dopamine (table 4) compared to Mobr/y mice treated with NaCI. The mean values in NaCl-treated Mobr/y mice were higher than those in -Cu mice, but much less than normal. However, following FeCl2 treatment, Mobr'y and -Cu norepinephrine levels were the same ( fig. 2) . Injection of CuCl2 into Mobr/y mice elevated the norepinephrine levels of brain, but to levels well below those of the other mice ( fig. 2) . Dopamine levels in Mobr/y mouse brain were not altered significantly by treatment with NaCI, FeCl2 or CuCl2, and levels were similar to those of the other three types of mice (table 4) . DISCUSSION A cursory comparison of young C57BL Mobr/y mice and -Cu mice suggests many gross similarities. Both are smaller than normal with reduced brain weight (6, 8) . Brain and liver have reduced levels of cop per (8) , and serum ceruloplasmin is very low (6, 8) . Whole-brain norepinephrine levels are also greatly depressed in both types of mice (6) . Injection of NaCI or FeCl2 into these "copper-deficient" mice did not alter any of these characteristics; however, injec tion of CuCl2 did. This suggests that the alterations were due to copper deficiency and not to secondary iron deficiency. The response of -Cu and Mobr/y mice to CuCl2 injection was quite different, however. In most cases, the -Cu mice demonstrated a much greater recovery than did the Mobr/y mice.
For example, body and brain weight in creases were noted in the â€" Cu mice treated with CuCl2 but not the Mobr/y mice. Others have noted that body weight of Mobr/y mice responds slowly to copper therapy following injection (9-11). Brain copper levels of -Cu mice returned to normal, whereas those of the Mobr/y mice were still below normal. Hunt originally reported no rise in brain copper levels in Mobr/y mice following CuCl2 (9) . However, most other reports (10, 13) , including more recent work from Hunt and Port (14) confirm the observations seen in the current studies, namely that the Â±179 (10) 562 Â±92.3 (4) 628 Â±213 (6) 522 Â±122 (8) 506 Â±134 (14) 498 Â±122 (11)419 Â±48.6 (3) 439 Â±63.7 (8) 536 Â±176 (12) 'Values are means Â±so (number of mice in parentheses) of 12-day-old male C57BL mice. Other details of the protocol can be found in table 1. 'Numbers within a row not sharing a common lower case superscript (com parison between mice) and numbers within a column not sharing a common upper case superscript (comparison between treatments) are significantly different (P < 0.01) by Student's t-test.
Mobr/y brain copper levels rise but are sus tained at less than normal levels. Our studies indicated that brain norepinephrine con centration returned to normal levels in Cutreated -Cu mice but not in Mobr/y mice. Hunt found normal norepinephrine levels in his Mobr'y Cu-treated mice (9), but brain copper levels in those Cu-treated mice were twice as high as those in the current study, suggesting a more "copper-deficient" state in our C57BL Mobr/y Cu-treated mice.
Liver copper levels in Cu-treated -Cu mice were elevated to the same levels as in control mice (+Cu and Mo*'?). Although liver copper rose in Cu-treated Mobr'y mice, the levels achieved were well below those of the other mice. This response in Mobr/y mice was noted by others following copper treatment (9, 10, 14) . The results of the cur rent studies with a large dose of copper are similar to those in which a smaller dose (1.2 Â¡ig labeled with 87Cu) was administered subcutaneously (15) . Those studies indicated that the brindled mice did not accumulate as much 67Cu in liver as did â€" Cu mice. The larger dose of copper used in the present studies, while not raising Mobr/y levels of liver copper beyond the control basal levels, was sufficient to allow ceruloplasmin activity to rebound to normal levels. Control mice ( + Cu and Mo+/y) accumulated copper in liver following injection, presumably for biliary export.
Brindled mice have elevated levels of liver iron (2, 8) and this was observed again in these studies. This elevation is not correlated with anemia, since the Mobr/y liver iron levels are higher than the -Cu levels (2, 8) and the Mobr/y mice are not anemic. Liver iron increased further in FeCl2-treated "cop per-deficient" mice but not in the controls (+Cu or Mo*'y). CuCl2 treatment affected Mobr/y and -Cu mice differently. The response in â€" Cu mice, which were anemic, is characteristic of "copper-deficient" ani mals, a lowering of elevated liver iron levels on copper treatment (16) . The lack of re sponse in the Mobr/y mice treated with CuCl2 suggests that the iron accumulation may be caused by some other mechanism. Liver iron levels of -i-Cu and Mo*'y mice are the same (2, 8) and were not altered by treatment with NaCl, FeCl2, or CuCl2. The diet of the dams nursing the -Cu and Mobr/y mice contain adequate iron, 45 and 210 ppm Fe, respectively. However, milk samples from these dams must be analyzed to determine if the reduction of dietary cop per in the case of -Cu dams or the brindled mutation in the case of the Mobr/y dams has altered iron levels of the milk.
Studies with rats have shown that an in verse relationship exists between copper and iron in liver (17) . Copper-deficient rats ac cumulate iron, and iron-deficient rats ac cumulate copper. Accumulation of copper Values of NE for -Cu mice were lower than Mobr/yfor the NaCI but not the FeCl2 treatment (P < 0.01); FeClj did not raise NE levels in either mouse type, but CuCl2 did (P < 0.01). The levels in CuCl2-treated -Cu mice were equal to +Cu and Mo*'yand levels in all three groups were higher (P < 0.01) than those in Mobr/y mice. m iron deficiency is also true of suckling rats (18) . Marston et al. have, in fact, shown (19) that iron injection into rats deficient in both copper and iron resulted in a lowering of liver copper levels, even though they were greatly depressed prior to injection. Our study did not show a decrease in liver copper levels in -Cu mice injected with FeCl2. How ever, there was a small rise in ceruloplasmin activity from 0.27 to 0.75 U/L. This mobili zation of liver copper may have been caused by the elevation in liver iron which also occurred. Since less than 1 ng of copper was injected with the FeCl2 solution, it is un likely that the rise in ceruloplasmin activity was due to copper from the injectate.
Rats deficient in both iron and copper when given an iron supplement accumulate liver iron, but no rise in hemoglobin occurs (16, 19) . This phenomenon is true for other species, and it is widely accepted that cop per must be given to observe a hemoglobin response (20) . The -Cu mice in our study accumulated iron beyond control levels and these levels rose following FeCl2 treatment.
However, FeCl2 treatment also increased hemoglobin levels in the -Cu mice. This observation seems contradictory to dogma but is consistent with the results of Weisenberg et al. (3) in rats. Others have reported a similar effect, a rise in hemoglobin levels in copper-deficient rats given an iron sup plement, but have not emphasized this ob servation (21) . The copper-deficient rat studies by Weisenberg et al. (3) were atypi cal because the liver iron levels of their rats were below normal, rather than elevated as is normally observed. Perhaps their "copperdeficient" rats responded to an iron sup plement because they were also iron-defi cient. The copper-deficient diet they used (22) contained 26 ppm Fe (by my calcula tion); this might be somewhat marginal. However, the -Cu mice in the current study showed no signs of an iron-deficient state (8) and thus the iron-dependent hemo globin response was quite unexpected. The â€" Cu mice responded as predicted (16, 19, 20) when injected with CuCl2, a rise in hemoglobin with a lowering of liver iron levels. Further work is obviously necessary to determine the exact nature of the copperdependent anemia in mice and the conse quences, if any, of this anemia.
